- Home
- SA vs CORT Comparison
SA vs CORT Comparison
Compare SA & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SA | CORT |
|---|---|---|
| Founded | 1979 | 1998 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SA | CORT |
|---|---|---|
| Price | $36.10 | $44.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $65.00 | ★ $114.20 |
| AVG Volume (30 Days) | 1.1M | ★ 3.3M |
| Earning Date | 11-12-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | ★ $741,172,000.00 |
| Revenue This Year | N/A | $21.70 |
| Revenue Next Year | N/A | $30.13 |
| P/E Ratio | ★ N/A | $50.35 |
| Revenue Growth | N/A | ★ 17.92 |
| 52 Week Low | $9.40 | $32.99 |
| 52 Week High | $37.99 | $117.33 |
Technical Indicators
Market Signals| Indicator | SA | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 71.21 | 40.15 |
| Support Level | $30.04 | $34.06 |
| Resistance Level | $32.03 | $37.48 |
| Average True Range (ATR) | 1.71 | 2.03 |
| MACD | 0.42 | 1.33 |
| Stochastic Oscillator | 79.83 | 94.99 |
Price Performance
Historical ComparisonAbout SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.